FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

23415211000001103: Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Nov 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
76653401000001114 Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
76653501000001113 Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has excipient Edetic acid true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Is a Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has active ingredient Buprenorphine false Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has manufactured dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has excipient Edetic acid false Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Is a Natzon true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Has basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) 7 tablet Has AMP True Natzon 8mg sublingual tablets (Morningside Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start